Maxim Group analyst Allen Klee maintains Health In Tech (NASDAQ:HIT) with a Buy and lowers the pr

Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript

Health In Tech NASDAQ: HIT reported second-quarter revenue of $8.1 million, down 13.5% from $9.3 mil

Health In Tech (NASDAQ:HIT) released second-quarter financial results and hosted an earnings call on

Health In Tech (NASDAQ:HIT) affirms FY2026 sales outlook from $45.000 million-$50.000 million to $45

Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.04) per share which missed the analyst

Contracted Revenue of $32.3 Million as of June 30, 2026 Pipeline Revenue of $66.3 Million as of July

STUART, Fla., Aug. 3, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTe

Health In Tech, Inc. (NASDAQ:HIT) ("Health In Tech" or the "Company") was added as a

STUART, Fla., June 29, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or

https://www.sec.gov/Archives/edgar/data/2019505/000121390026067420/ea0293871-s3_health.htm

Health In Tech, Inc. (HIT) Q1 2026 Earnings Call Transcript

Health In Tech NASDAQ: HIT reported first-quarter 2026 revenue growth and a wider loss as management

Health In Tech (NASDAQ:HIT) affirms FY2026 sales outlook from $45.000 million-$50.000 million to $45

Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.03) per share which met the analyst con

Reiterates Guidance for 2026 Annual Revenue Ranging between $45 Million and $50 Million STUART, Fla.

STUART, Fla., April 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled Insur

FDA provided critical guidance for the advancement of CAD-1005 to pivotal Phase 3 in HIT Phase 2 dat

STUART, Fla., April 21, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) (the "Company"), an

Craig-Hallum analyst George Sutton initiates coverage on Health In Tech (NASDAQ:HIT) with a Buy r

STUART, Fla., March 27, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or

Health In Tech, Inc. (HIT) Q4 2025 Earnings Call Transcript

Health In Tech, Inc. (NASDAQ:HIT) ("Health In Tech" or the "Company"), an AI-enabled

STUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or

Health In Tech (NASDAQ:HIT) sees FY2026 sales of $45.000 million-$50.000 million vs $42.035 million

Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.01) per share which met the analyst con

Full year 2025 Revenues of $33.3 million, up 71% YoY Full year 2025 Adjusted EBITDA of $4.1 million,

Energy Vault Holdings Inc (NYSE: NRGV) rose in pre-market trading after beating earnings estimates a

Health In Tech Inc. jumped 27.65% in after-hours trading following a partnership announcement with A

Health In Tech Inc. jumped 27.65% in after-hours trading following a partnership announcement with A

Health In Tech, Inc. (the "Company" or "Health In Tech") (NASDAQ:HIT), an AI-enabled

STUART, Fla., March 17, 2026 /PRNewswire/ -- Health In Tech, Inc. (the "Company" or "Health In Tech"

STUART, Fla., March 9, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurT

Barclays PLC increased its holdings in shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH) by

Barclays PLC lifted its holdings in Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 41.7% in the

Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, tod

AlphaTON Capital Corp. (NASDAQ:ATON) ("AlphaTON" or the "Company"), a specialized di

Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, toda

Health In Tech (NASDAQ:HIT) reported quarterly earnings of $0.01 per share which met the analyst con

Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, toda

Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, is p

Health In Tech (NASDAQ:HIT) reported quarterly earnings of $0.01 per share which met the analyst con

Maxim Group analyst Allen Klee initiates coverage on Health In Tech (NASDAQ:HIT) with a Buy ratin